Loading news...
Although the revenue and EPS for H. B. Fuller (FUL) give a sense of how its business performed in the quarter ended November 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) today reported financial results for its fourth quarter and fiscal year that ended November 29, 2025. Fourth Quarter 2025 Noteworthy Items: Net revenue was $895 million, down 3.1% year-on-year; adjusting for the flooring divestiture, net revenue was up 0.9% year-on-year; Gross margin was 31.5%; adjusted gross margin of 32.5% increased 290 basis points year-on-year driven by favorable pricing and raw material cost actions, the imp.
H.B. Fuller Company (NYSE: FUL) will release earnings results for the fourth quarter, after the closing bell on Wednesday, Jan. 14.
Besides Wall Street's top-and-bottom-line estimates for H. B. Fuller (FUL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended November 2025.
H. B. Fuller Company (NYSE: FUL - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the nine ratings firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, three have given a buy recommendation and two
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) announced plans to report its financial results for the three-month and twelve-month fiscal periods ended November 29, 2025, in a press release issued after the market close on January 14, 2026. The Company will hold an investor conference call on January 15, 2026, at 9:30 a.m. CT (10:30 a.m. ET) to discuss its financial results. Interested parties may listen to the conference call on a live webcast. The webcast, along with a sup.
Dividend Kings underperformed SPY in 2025, up 4.47% vs. SPY's 17.7%, but select Kings outperformed the index. Twenty-two Dividend Kings are identified as both potentially undervalued and offering long-term expected annualized returns of at least 10%. Dividend growth for the Kings remains subdued at 5.81% for 2025, trailing the 2024 rate of 6.32%.
Deprince Race and Zollo Inc. raised its stake in shares of H. B. Fuller Company (NYSE: FUL) by 80.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 555,877 shares of the specialty chemicals company's stock after acquiring an
Mativ (NYSE: MATV - Get Free Report) and H. B. Fuller (NYSE: FUL - Get Free Report) are both basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends. Profitability This table compares Mativ and H.
H.B. Fuller (NYSE:FUL) manufactures adhesives and sealants globally.
H. B. Fuller Company (NYSE: FUL - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the nine analysts that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, three have assigned a buy recommendation and
Atria Investments Inc raised its stake in shares of H. B. Fuller Company (NYSE: FUL) by 29.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,685 shares of the specialty chemicals company's stock after buying an additional 1,766 shares during the
H.B. Fuller CFO John Corkrean sold shares worth approximately $857,800 on Oct. 27, 2025. H.B. Fuller Company is having a tough year with fiscal third quarter sales down 3% year over year to $892 million.
Mutual of America Capital Management LLC lowered its stake in H. B. Fuller Company (NYSE: FUL) by 94.2% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 6,962 shares of the specialty chemicals company's stock after selling 113,952 shares during
H.B. Fuller Company (NYSE:FUL ) Analyst/Investor Day October 20, 2025 1:00 PM EDT Company Participants John Corkrean - Executive VP & CFO Celeste Mastin - President, CEO & Director Brendon Kryzer Nathanial Weaver - Executive Vice President of Business Transformation Scott Jensen - Investor Relations Conference Call Participants Michael Harrison - Seaport Research Partners Patrick Cunningham - Citigroup Inc., Research Division David Begleiter - Deutsche Bank AG, Research Division Kevin McCarthy - Vertical Research Partners, LLC Ghansham Panjabi - Robert W. Baird & Co. Incorporated, Research Division Wenyi Huang - JPMorgan Chase & Co, Research Division Rosemarie Morbelli Presentation John Corkrean Executive VP & CFO Good afternoon.
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller (NYSE: FUL), the largest pureplay adhesives company in the world, today announced the transformation of its foundation with the launch of Fuller Impact. This new global platform unites philanthropic investments and community engagement under one purpose: to create stronger communities through innovation, collaboration, and sustained improvement. “Through Fuller Impact, we are deepening our commitment to advancing social good by empowering communitie.
This October's Dividend Kings list features 56 stocks, with Kenvue and United Bankshares meeting the ideal "fair price" yield criteria. Analysts project the top-ten Dividend Kings could deliver 19.2% to 41.5% net gains by October 2026, with KVUE offering the highest upside. Only two of the top-ten Kings, KVUE and UBSI, are considered "safer" with sufficient free cash flow to cover their dividends at current prices.
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL), the largest pureplay adhesives manufacturer in the world, today announced the appointment of Celine Martin to its Board of Directors, effective December 1, 2025. Ms. Martin brings more than 30 years of experience in the global MedTech industry, with deep expertise across surgical, cardiology, endovascular, and neurovascular segments. Her appointment reinforces H.B. Fuller's strategic focus on expanding its presence in high-margi.
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) today announced that it is hosting its 2025 Investor Day live and by webcast on Monday, October 20, 2025, at the Conrad New York Downtown Hotel in New York, NY. The conference will feature remarks by President and CEO Celeste Mastin and other key members of H.B. Fuller's management team. The Company will give a comprehensive update on its strategic vision, financial performance, and overall long-term value creation strategy. Due.